Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 205

1.

p53 nuclear accumulation and ERalpha expression in ductal hyperplasia of breast in a cohort of 215 Chinese women.

Mao XY, Fan CF, Zheng HC, Wei J, Yao F, Jin F.

J Exp Clin Cancer Res. 2010 Aug 16;29:112. doi: 10.1186/1756-9966-29-112.

PMID:
20712900
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor.

Xu S, Wei B, Zhang H, Qing M, Bu H.

Oncol Rep. 2008 Jun;19(6):1469-75.

PMID:
18497952
[PubMed - indexed for MEDLINE]
3.

[Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions].

Zhang N, Sun ZZ, Li F, Cao YW, Zhao CX, Liang WH, Sun HP, Li HA, Fu XG.

Zhonghua Bing Li Xue Za Zhi. 2011 May;40(5):324-9. Chinese.

PMID:
21756827
[PubMed - indexed for MEDLINE]
4.

[Role of cytokeratin expression in differential diagnosis of intraductal proliferative lesions of breast].

Zhang JL, Zhang HY, Wei B, Lang ZQ, Bu H.

Zhonghua Bing Li Xue Za Zhi. 2004 Aug;33(4):316-9. Chinese.

PMID:
15363314
[PubMed - indexed for MEDLINE]
5.

Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.

Steinman S, Wang J, Bourne P, Yang Q, Tang P.

Ann Clin Lab Sci. 2007 Spring;37(2):127-34.

PMID:
17522367
[PubMed - indexed for MEDLINE]
6.

Bax protein expression in DCIS of the breast in relation to invasive ductal carcinoma and other molecular markers.

Rehman S, Crow J, Revell PA.

Pathol Oncol Res. 2000;6(4):256-63.

PMID:
11173657
[PubMed - indexed for MEDLINE]
Free Article
7.

HER2 as a prognostic factor in breast cancer.

Ménard S, Fortis S, Castiglioni F, Agresti R, Balsari A.

Oncology. 2001;61 Suppl 2:67-72. Review.

PMID:
11694790
[PubMed - indexed for MEDLINE]
8.

[Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].

Yang M, Xu SP, Ao QL.

Zhonghua Bing Li Xue Za Zhi. 2013 Apr;42(4):257-61. doi: 10.3760/cma.j.issn.0529-5807.2013.04.010. Chinese.

PMID:
23928534
[PubMed - indexed for MEDLINE]
9.

bcl-2 expression in the spectrum of preinvasive breast lesions.

Siziopikou KP, Prioleau JE, Harris JR, Schnitt SJ.

Cancer. 1996 Feb 1;77(3):499-506.

PMID:
8630957
[PubMed - indexed for MEDLINE]
10.

Expression of centrosomal tubulins associated with DNA ploidy in breast premalignant lesions and carcinoma.

Niu Y, Wang S, Liu T, Zhang T, Wei X, Wang Y, Jiang L.

Pathol Res Pract. 2013 Apr;209(4):221-7. doi: 10.1016/j.prp.2012.12.006. Epub 2013 Mar 21.

PMID:
23523041
[PubMed - indexed for MEDLINE]
11.

Immunohistochemical analysis on biological markers in ductal carcinoma in situ of the breast.

Iwase H, Ando Y, Ichihara S, Toyoshima S, Nakamura T, Karamatsu S, Ito Y, Yamashita H, Toyama T, Omoto Y, Fujii Y, Mitsuyama S, Kobayashi S.

Breast Cancer. 2001;8(2):98-104.

PMID:
11342981
[PubMed - indexed for MEDLINE]
12.
13.

p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin.

Megha T, Ferrari F, Benvenuto A, Bellan C, Lalinga AV, Lazzi S, Bartolommei S, Cevenini G, Leoncini L, Tosi P.

J Clin Pathol. 2002 Jun;55(6):461-6.

PMID:
12037031
[PubMed - indexed for MEDLINE]
Free PMC Article
14.
15.

Expression of ER, Ki-67 and cylinD1 in the pre-cancerous breast of Chinese patients.

Zhou CJ, Zhang QH, Zhang TG, Sun SZ, Li H, Wang Y, Liu ZY.

Pathol Oncol Res. 2009 Jun;15(2):153-8. doi: 10.1007/s12253-008-9100-6. Epub 2008 Oct 22.

PMID:
18941930
[PubMed - indexed for MEDLINE]
16.

Immunohistochemical analysis of 14-3-3 sigma and related proteins in hyperplastic and neoplastic breast lesions, with particular reference to early carcinogenesis.

Simooka H, Oyama T, Sano T, Horiguchi J, Nakajima T.

Pathol Int. 2004 Aug;54(8):595-602.

PMID:
15260850
[PubMed - indexed for MEDLINE]
17.

Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.

Papantoniou V, Sotiropoulou E, Valsamaki P, Tsaroucha A, Sotiropoulou M, Ptohis N, Stipsanelli A, Dimitrakakis K, Marinopoulos S, Tsiouris S, Antsaklis A.

Breast Cancer. 2011 Oct;18(4):286-91. doi: 10.1007/s12282-009-0192-y. Epub 2010 Feb 9.

PMID:
20143189
[PubMed - indexed for MEDLINE]
18.

Alterations of ER, PR, HER-2/neu, and P53 protein expression in ductal breast carcinomas and clinical implications.

Liu C, Zhang H, Shuang C, Lu Y, Jin F, Xu H, Lu P.

Med Oncol. 2010 Sep;27(3):747-52. doi: 10.1007/s12032-009-9279-8. Epub 2009 Aug 6.

PMID:
19657752
[PubMed - indexed for MEDLINE]
19.

Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family.

Abdel-Fatah TM, Powe DG, Hodi Z, Reis-Filho JS, Lee AH, Ellis IO.

Am J Surg Pathol. 2008 Apr;32(4):513-23. doi: 10.1097/PAS.0b013e318161d1a5.

PMID:
18223478
[PubMed - indexed for MEDLINE]
20.

p63 Staining of myoepithelial cells in breast fine needle aspirates: a study of its role in differentiating in situ from invasive ductal carcinomas of the breast.

Reis-Filho JS, Milanezi F, Amendoeira I, Albergaria A, Schmitt FC.

J Clin Pathol. 2002 Dec;55(12):936-9.

PMID:
12461063
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk